| Excesses
of estrogen and progesterone - including excesses of molecules
and compounds with estrogen-like and progesterone-like effects
- interfere with cell and tissue function. Interference with
cell and tissue function will lead to symptoms and disease,
sooner or later. This is why some women have unwanted effects
when taking a hormone therapy.
Estrogen and progesterone are lipids. They are anti-inflammatory
lipids. Anti-inflammatory lipids in excess interfere
with cell and tissue oxygen, electrolyte and mineral metabolisms.
When considering hormone replacement it is adviseable to ask
whether a woman already has excess anti-inflammatory lipids;
or whether, by adding hormones, she will now have excess anti-inflammatory
lipids.
If a patient's Anti-Free radical Activity (Anti-FRA) score is
high, i.e. above 35, this woman already has excess anti-inflammatory
lipids. If adding hormones, or supplements with hormonal effects,
decreases the Anti-FRA score, she is deficient in hormones.
The hormones have replaced the other compensatory anti-inflammatory
lipids, lipids that do not have the necessary hormonal effects.
The hormones will be benefically as hormones AND will improve
overall health. If adding hormones, however, does not result
in a decrease in a high Anti-FRA, or if hormones increase the
Anti-FRA, this woman now has excess anti-inflammatory lipids.
She therefore is at risk for developing unwanted effects, sooner
or later.
The other score to monitor in all patients taking hormone therapy
is the Free Radical Index(FRA). Free radicals are produced by
pro-inflammatory lipids. Testosterone is a pro-inflammatory
lipid. The same holds true for testosterone and the FRA score
as described above for estrogen and progesterone and the Anti-FRA
score. If a man or woman's high FRA decreases with testosterone
therapy the therapy is safe and beneficial. However, if a high
FRA score does not decrease, or if the FRA increases, testosterone
therapy alone is contraindicated. Combinations of hormones will
have their unique composite effects in each individual. It is
possible testosterone in combination with other hormones will
not increase the FRA score in some individuals even when testosterone
alone does result in an increase.
Use both the Anti-FRA score and the FRA score before and during
(and after, if applicable) hormone therapy...to minimize risk
and optimize benefits. These scores monitor hormone therapies
for menopause, bone density, contraception, body building, heart
disease, cancer and more. The Anti-FRA and FRA scores allow
you to use all hormones, in varying combinations and in both
women and men, to optimize health and natural aging.
© Health
Equations 2007
PRINT
CLOSE WINDOW |